Medical Director, Clinical Development - Cardio Gene Therapy

Eli Lilly and Company; Boston (MA); On-site; USD 243,000 - 394,000; Full time

Benefits offered by this job

401(k) plan

Pension

Vacation benefits

Medical, dental, vision

Job summary

Verve Therapeutics – a wholly owned subsidiary of Eli Lilly and Company – seeks a Senior Medical Director, Clinical Development to lead clinical trial efforts for gene editing therapies targeting cardiovascular disease.

You will provide medical oversight throughout the trial lifecycle, drive regulatory submissions, and partner with cross-functional teams to shape biomarker strategies and asset transition from early to later phases.

Qualifications

• Medical Doctor with board eligibility or certification in a relevant specialty.
• U.S. trained physicians must have board eligibility or certification.
• Experience overseeing clinical trials; 7+ years preferred.
• Knowledge of GCP and regulatory guidelines.

Responsibilities

• Provide medical oversight and strategic leadership across the clinical trial lifecycle.
• Draft and review protocols, investigators' brochures, and informed consent materials.
• Ensure development strategy adheres to regulatory guidelines while collaborating with investigators.
• Lead the review of clinical trial data for safety and efficacy.
• Represent Lilly at scientific conferences and regulatory meetings.
• Collaborate with cross-functional teams to advance programs and biomarker strategies.
• Travel to sites and conferences as needed.

Skills

Medical oversight

Regulatory knowledge

Clinical trial design

Leadership

Education

MD/DO

Job description

Verve Therapeutics – a wholly owned subsidiary of Eli Lilly and Company – seeks a Senior Medical Director, Clinical Development to lead clinical trial efforts for gene editing therapies targeting cardiovascular disease.

You will provide medical oversight throughout the trial lifecycle, drive regulatory submissions, and partner with cross-functional teams to shape biomarker strategies and asset transition from early to later phases.